Rane K, Sollevi A, Segerdahl M
Department of Anaesthesia and Intensive Care, Danderyd Hospital, Sweden.
Acta Anaesthesiol Scand. 2000 Aug;44(7):868-72. doi: 10.1034/j.1399-6576.2000.440714.x.
Adenosine (Ado) is known, from studies in both animals and humans, to produce antinociception when administered systemically or intrathecally (IT). The current aim was to evaluate, in a placebo-controlled, randomised, double-blind study, whether IT adenosine given before surgery could reduce anaesthetic requirement and the need of opioids during 48 h after visceral surgery.
Forty women (37-66 years, ASA I and II) scheduled for elective hysterectomy were included. Before inducing the standardised O2/N2O/isoflurane/fentanyl anaesthesia, the patients received an IT injection of either adenosine (500 microg in 1 ml volume) or placebo 1 ml (saline). Intraoperative anaesthetic drug doses and haemodynamics were recorded. Postoperative pain was assessed by visual analogue scale. For postoperative analgesia, cetobemidone was provided via intravenous patient-controlled analgesia (PCA).
During surgery, there were no differences between groups in anaesthetic requirement or haemodynamic parameters. Postoperative cetobemidone requirements were similar in both groups (median 48 mg for adenosine/50 mg for saline) during the first 48 postoperative hours.
IT adenosine did not influence the requirement of anaesthetic drug or postoperative analgesics after hysterectomy.
动物和人体研究均表明,全身或鞘内注射(IT)腺苷(Ado)可产生抗伤害感受作用。本研究旨在通过一项安慰剂对照、随机、双盲试验,评估术前鞘内注射腺苷是否能降低内脏手术后48小时内的麻醉药物需求量及阿片类药物的使用需求。
纳入40例计划行择期子宫切除术的女性患者(年龄37 - 66岁,ASA I级和II级)。在诱导标准化的氧气/氧化亚氮/异氟烷/芬太尼麻醉前,患者接受鞘内注射腺苷(500微克,1毫升)或安慰剂1毫升(生理盐水)。记录术中麻醉药物剂量及血流动力学指标。术后疼痛采用视觉模拟评分法评估。术后镇痛通过静脉自控镇痛(PCA)给予西托贝米酮。
手术过程中,两组在麻醉药物需求量或血流动力学参数方面无差异。术后48小时内,两组术后西托贝米酮需求量相似(腺苷组中位数为48毫克/生理盐水组为50毫克)。
鞘内注射腺苷对子宫切除术后麻醉药物及术后镇痛药物的需求量无影响。